Antigen negative gastrointestinal histoplasmosis in an AIDS patient

被引:6
作者
Escobar, Betsy
Maldonado, Victoria N.
Ansari, Sofia [1 ]
Sarria, Juan C.
机构
[1] Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA
来源
AMERICAN JOURNAL OF CASE REPORTS | 2014年 / 15卷
关键词
AIDS; HIV Enteropathy; Histoplasmosis;
D O I
10.12659/AJCR.889940
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Adverse events of drug therapy Background: Gastrointestinal involvement in patients with disseminated histoplasmosis is considered common since the organism is identified in the GI tract of approximately 70-90% of autopsy cases. This infection is rarely recognized by clinicians due to its non-specific symptoms. Lesions may occur anywhere in the GI tract but most commonly affects the terminal ileum. Patients present with GI bleeding, intestinal obstruction, ulcerations, masses, and peritonitis. Serum and urine serological antigens are useful for diagnosis because they are positive in over 90% of patients with disseminated disease but may be falsely negative in patients with localized GI involvement. Although histopathology and tissue cultures are specific, limitations include insensitivity and need for invasive procedures. Antifungal agents include intravenous amphotericin B for severe or unstable disease and oral itraconazole for stable disease. Case Report: A 51-year-old HIV positive female presented with abdominal pain, nausea and vomiting. A CT scan of the abdomen revealed circumferential narrowing around a segment of the sigmoid colon with the cecum demonstrating irregular thickened walls. A biopsy of an obstructing duodenal mass found on endoscopy revealed granulomatous inflammation and budding yeasts consistent with Histoplasma spp. She was started on intravenous liposomal amphotericin B and after 2 weeks switched to itraconazole oral solution. Urine and serum histoplasma antigens sent out 2 weeks after antifungal treatment were negative. Conclusions: This case report illustrates the importance of recognizing gastrointestinal histoplasmosis in AIDS patients presenting with non-specific GI symptoms.
引用
收藏
页码:90 / 93
页数:4
相关论文
共 12 条
[1]  
Kahi C.J., Wheat L.J., Allen S.D., Sarosi G.A., Gastrointestinal Histoplasmosis, Am J Gastroenterology, 100, pp. 220-231, (2005)
[2]  
Jain S., Koirala J., Castro-Pavia F., Isolated Gastrointestinal Histoplasmosis: Case Report and Review of the Literature, South Med J, 97, pp. 172-174, (2004)
[3]  
Haws C.C., Long R., Caplan G., Histoplasma capsulatum as a cause of ileocolitis, Am J Roentgenol, 128, pp. 692-694, (1977)
[4]  
Brennan-Benson P., Lyus R., Harrison T., Et al., Pharmacokinetic interactions between efavirenz and rifampin in the treatment of HIV and tuberculosis: One size does not fit all, AIDS, 19, pp. 1541-1543, (2005)
[5]  
Nacher M.S.F., Increased Incidence of Disseminated Histoplasmosis Following Highly Active Antiretroviral Therapy, J Acquir Immune Defic Syndr, 41, pp. 468-470, (2006)
[6]  
Srinivasan A., Kleiman M.B., Debelenko L., Et al., False-negative Histoplasma antigen in acute pulmonary histoplasmosis: The value of urinary concentration by ultrafiltration and heat denaturation of serum proteins in detection of Histoplasma antigen, Pediatr Infect Dis, 28, pp. 447-449, (2009)
[7]  
De Beule K., Van Gestel J., Pharmacology of itraconazole, Drugs, 61, pp. 27-37, (2001)
[8]  
Koo H., Hamill R.J., Andrade R.A., Drug-Drug Interaction between Itraconazole and Efavirenz in a Patient with AIDS and disseminated Histoplasmosis, Clin Infect Dis, 45, pp. 77-79, (2007)
[9]  
Ma Q., Okusanya O.O., Smith P.F., Et al., Pharmacokinetic drug interactions with non-nucleoside reverse transcriptase inhibitors, Expert Opin Drug Metab Toxicol, 1, pp. 473-485, (2005)
[10]  
Connolly P.A., Durkin M.M., LeMonte A.M., Et al., Detection of Histoplasma Antigen by a Quantitative Enzyme Immunoassay, Clin Vaccine Immunol, 14, pp. 1587-1591, (2007)